Spectral Medical Inc. (EDT:CA) Discusses Year-End Update: FDA Filing Timeline, Tigris Trial Results, and Commercialization Readiness Transcript

PresentationI will now turn the conference over to Ali Mahdavi, Capital Markets and Investor Relations. Thank you. You may begin.Ali MahdaviSpinnaker Capital Markets Inc. Thank you, Sherry. Good morning, everyone, and thanks for joining us for today's year-end corporate update call. Joining me this morning are Chris Seto, Chief Executive Officer of Spectral Medical; and Dr. John Kellum, Spectral's Chief Medical Officer. Following remarks from Chris and John, we will open the call for a Q&A session. Before ...